Finance Thomas Culman Finance Thomas Culman

What are smart ways boards can identify and negotiate opportunities to save money?

The many fees and expenses associated with running any company are more than just a headache. Particularly for R&D-intensive biotech companies, failing to stay on top of them can significantly saddle a company with unnecessary cash burn. A new video resource at RA Capital's free Gateway platform for boards and biotech leadership features industry leaders sharing their experiences navigating these pesky financial challenges.

Read More
Finance, Policy, Biotech, Planetary Health Peter Kolchinsky Finance, Policy, Biotech, Planetary Health Peter Kolchinsky

Act now to prevent SVB’s failure from becoming a national crisis

The federal government must address the failure of Silicon Valley Bank (SVB) with speed and clarity before it metastasizes into a national crisis, so the ecosystem of institutions in which SVB has operated, including other banks and investors, can help bridge companies so that they can continue to operate while they wait for their deposits.

Read More